Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hofner K et al. – In men with symptoms of OAB and LUTS suggestive of non–obstructive BPH of all IPSS severity classes, aged <=65 years or above, with or without concomitant diabetes or alpha–blockers, symptoms and QoL improved markedly during treatment with tolterodine ER.


   

Related Articles

Differential Diagnosis of Overactive Bladder in Men
The Journal of Urology, 11/24/09    Relevance Score: 69%

Urinary urgency outcomes after propiverine treatment for an overactive bladder: the Propiverine study on overactive bladder including urgency data
BJU International, 11/24/09    Relevance Score: 69%

Fesoterodine for the Treatment of Overactive Bladder
Annals of Pharmacotherapy, 11/18/09    Relevance Score: 69%

The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09    Relevance Score: 69%

The relationship between sleep apnea and overactive bladder
Current Urology Reports, 11/17/09    Relevance Score: 68%

Today in Clinical Pharmacology...keeping you current

Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/19/10

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address